glp 1 and mood What do the studies actually show about GLP-1s mental health? • There have been reports of depression, anxiety, changes, and suicidal thoughts in some people taking GLP-1 medications like Ozempic Nature Made GLP-1 Companion Health

Hruby and Mac Hadley (University of Arizona, USA) in 19871989 Original development program Competitive Technologies Palatin Technologies , later spun off into PT-141 (bremelanotide) Target: non-selective agonist of MC1R, MC3R, MC4R, MC5R (more potent than -MSH, longer half-life) Standard experimental dose in human tanning studies: 0.025 mg/kg subcutaneously (Dorr 1996) In Dorr 1996 (n=10): increase in skin melanin density measured by colorimetry by ~25 % after a 10-day course Main adverse effects in the preclinical literature: nausea, flushing, hyperpigmentation (including atypical nevi), priapism Approximately 100+ publications in PubMed

De novo-designed transmembrane domains tune engineered receptor functions

2.3 Manifestations of nervous system injury METH abuse induces neurological damage that manifests as cognitive impairment, psychiatric symptoms, and motor dysfunction, with clear distinctions between the acute and chronic phases of use

Addressing these queries can provide clarity for those considering the treatment